← SynDRA
BUTAPROST
SynDRA canonical compound SYN0009137 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | PTGER2 |
|---|
| Mechanism of action | prostaglandin receptor agonist |
|---|
All known targets
- PTGER2
- PTGER1
- PTGER3
- PTGER4
- PTGFR
Mechanisms of action (all sources)
- prostaglandin receptor agonist
- PTGFR ANTAGONIST
- PTGER1 ANTAGONIST
- PTGER4 ANTAGONIST
- PTGER3 ANTAGONIST
- PTGER2 ANTAGONIST
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Cross-references
Synonyms
- BAY-Q-4218
- BAYQ-4218
- TR-4979
- (R)-Butaprost
- UNII-HP16WVP23Y
- HP16WVP23Y
- NCGC00165753-01
- Butaprostum
- (1R,2R,3R)-3-Hydroxy-2-[(1E,4R)-4-hydroxy-4-(1-propylcyclobutyl)-1-butenyl]-5-oxo-cyclopentaneheptanoic acid methyl ester
- Butaprostum [Latin]
- Butaprost [USAN:INN:BAN]
- Butaprost (free acid)
- AC1NSJVB
- Butaprost (USAN/INN)
- DSSTox_RID_83186
- DSSTox_CID_28919
- SCHEMBL94764
- DSSTox_GSID_48993
- CHEMBL271896
- GTPL3379
- DTXSID8048993
- BDBM85602
- ZINC4215145
- Tox21_113480
- MFCD00867055
- 1090AH
- PDSP2_001674
- DOH-CB-PGE1
- RefChem:917733
- BUTAPROST [INN]
- BUTAPROST [USAN]
- DTXCID4028919
- CHEBI:230184
- (R)-Butaprost, >=98% (HPLC)
- AC-31142
- DA-51479
- CAS-69648-38-0
- CAS_69648-38-0
Look up BUTAPROST in the interactive SynDRA portal →